# Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)

> **NCT00404547** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1121 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide
- **DRUG:** Usual Care Inhaled Glucocorticosteroids

## Key facts

- **NCT ID:** NCT00404547
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-04
- **Final completion:** 2008-12
- **Target enrollment:** 1121 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404547, "Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00404547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*